Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
CD44 variant isoforms control experimental autoimmune encephalomyelitis by affecting the lifespan of the pathogenic T cells.
Circulating CCR7+ICOS+ Memory T Follicular Helper Cells in Patients with Multiple Sclerosis.
ShcA Regulates Late Stages of T Cell Development and Peripheral CD4+ T Cell Numbers.
A case of neuromyelitis optica harboring both anti-aquaporin-4 antibodies and a pathogenic mitochondrial DNA mutation for Leber's hereditary optic neuropathy: clinical commentary.
Conjugal multiple sclerosis in Isfahan, Iran: a population-based study.
Cytoplasmic sphingosine-1-phosphate pathway modulates neuronal autophagy.
X-linked Charcot-Marie-Tooth disease type 6 (CMTX6) patients with a p.R158H mutation in the pyruvate dehydrogenase kinase isoenzyme 3 gene.
Olig1 Acetylation and Nuclear Export Mediate Oligodendrocyte Development.
Baseline Gene Expression Signatures in Monocytes from Multiple Sclerosis Patients Treated with Interferon-beta.
Incidence of the urological tumours in patients suffering from multiple sclerosis.
Neurodegenerative Diseases: from available treatments to prospective herbal therapy.
Magnetic resonance imaging reveals therapeutic effects of interferon-beta on cytokine-induced reactivation of rat model of multiple sclerosis.
Pharmacological treatments for fatigue associated with palliative care.
Energy expenditure during everyday activities - a study comparing people with varying mobility limitations due to multiple sclerosis and healthy controls.
IL-22 secreting CD4+ T cells in the patients with neuromyelitis optica and multiple sclerosis.
[Progressive Multifocal Leukoencephalopathy with Inflammatory Reactions].
CSF isoprostane levels are a biomarker of oxidative stress in multiple sclerosis.
Multiple sclerosis: Drug-enhanced remyelination in a multiple sclerosis model.
Comparative Effectiveness Using A Matching-Adjusted Indirect Comparison Between Delayed-Release Dimethyl Fumarate and Fingolimod for The Treatment of Relapsing-Remitting Multiple Sclerosis.
Antibody-Mediated Inhibition of TNFR1 Attenuates Disease in a Mouse Model of Multiple Sclerosis.
A 62-year-old man with fluctuating neurological deficits and skin lesions.
Natalizumab (TYSABRI) and multiple sclerosis. With longer follow-up: even more toxic than suspected.
Rosuvastatin enhances anti-inflammatory and inhibits pro-inflammatory functions in cultured microglial cells.
Diagnostic ability of a new method for measuring haemoglobin levels in the optic nerve head in multiple sclerosis patients.
Distribution of axon diameters in cortical white matter: an electron-microscopic study on three human brains and a macaque.
Pages
« first
‹ previous
…
473
474
475
476
477
478
479
480
481
…
next ›
last »